BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1459529)

  • 1. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
    Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
    Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
    Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
    Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
    Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
    Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
    Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis.
    Togo S; Tanaka K; Morioka D; Sugita M; Ueda M; Miura Y; Kubota T; Nagano Y; Matsuo K; Endo I; Sekido H; Shimada H
    Nutrition; 2005 Apr; 21(4):480-6. PubMed ID: 15811769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three targets of branched-chain amino acid supplementation in the treatment of liver disease.
    Holecek M
    Nutrition; 2010 May; 26(5):482-90. PubMed ID: 20071143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
    Bauer AG; Wilson JH; Lamberts SW; Blom W
    Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy (CHE) of patients with liver cirrhosis.
    Schäfer K; Winther MB; Ukida M; Leweling H; Reiter HJ; Bode JC
    Z Gastroenterol; 1981 Jul; 19(7):356-62. PubMed ID: 7293293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
    Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
    J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial.
    Sieg A; Walker S; Czygan P; Gärtner U; Lanzinger-Rossnagel G; Stiehl A; Kommerell B
    Z Gastroenterol; 1983 Nov; 21(11):644-50. PubMed ID: 6362243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic oral branched-chain amino acid supplementation in a subpopulation of cirrhotics.
    Dioguardi FS; Brigatti M; Dell'Oca M; Ferrario E; Abbiati R
    Clin Physiol Biochem; 1990; 8(2):101-7. PubMed ID: 2361352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status.
    Kawamura E; Habu D; Morikawa H; Enomoto M; Kawabe J; Tamori A; Sakaguchi H; Saeki S; Kawada N; Shiomi S
    Liver Transpl; 2009 Jul; 15(7):790-7. PubMed ID: 19562716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients.
    Tangkijvanich P; Mahachai V; Wittayalertpanya S; Ariyawongsopon V; Isarasena S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):152-7. PubMed ID: 11023085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture.
    Nakaya Y; Harada N; Kakui S; Okada K; Takahashi A; Inoi J; Ito S
    J Gastroenterol; 2002; 37(7):531-6. PubMed ID: 12162411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplementation with branched-chain amino acids attenuates hepatic apoptosis in rats with chronic liver disease.
    Kuwahata M; Kubota H; Kanouchi H; Ito S; Ogawa A; Kobayashi Y; Kido Y
    Nutr Res; 2012 Jul; 32(7):522-9. PubMed ID: 22901560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment.
    Bresci G; Parisi G; Banti S
    Eur J Med; 1993; 2(7):414-6. PubMed ID: 8258031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
    Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
    Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.